• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Morepen Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen
  • BSE Code : 2685.0
  • ISIN : INE083A01026
49.38 2 (3.22%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    47.85

  • Today’s High

    49.75

  • Open

    47.90

  • Perv Close

    47.84

  • 52W Low

    42.05

  • 52W High

    100.90

Key Indicators

  • P/E(TTM)

    20.83

  • Mar.Cap (₹Cr.)

    2,705.80

  • Div & Yield %

    0.00

  • Book Value(₹)

    20.95

  • Debt-Equity Ratio

    3.22

  • AGM Date

    01-Apr-2025

  • EPS

    2.37

  • P/E Ratio

    20.83

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    2,705.80

  • RONW (%)

    12.08

  • ROCE (%)

    16.12

Score Board

  • Equity (₹ in Cr.)

    109.59

  • BV (₹)

    21.00

  • Sales( ₹ in Cr.)

    1,537.59

  • NP (in Cr.)

    110.94

  • NP Var(%)

    140.0

  • Div%

    0.0

  • CPS (₹)

    2.40

  • EPS (₹)

    2.00

  • Traded Value (₹ in Lakhs)

    2,704.70

  • 52 Week High

    100.90

  • 52 Week Low

    42.05

  • Price BSE

    49.0

  • Price NSE

    49.00

  • Market Capital( in Cr.)

    2,704.70

  • P/C Ratio

    20.20

  • P/E Ratio

    24.20

  • Price Vs.BV

    2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24
Excise Duty 1,529.43 1,335.48 1,446.05 1,101.72 779.86 705.97
Net Sales 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24
Other Income 12.57 5.76 10.24 11.77 9.42 3.67
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,550.16 1,344.64 1,459.50 1,124.20 801.40 720.91
EXPENDITURE :
Raw Materials 1,529.43 1,335.48 1,446.05 1,101.72 779.86 705.97
Power & Fuel Cost 1,529.43 1,335.48 1,446.05 1,101.72 779.86 705.97
Employee Cost 160.28 146.19 150.00 123.20 98.07 84.74
Other Manufacturing Expenses 23.47 43.19 49.36 31.30 11.89 11.11
Selling & Administrative Expenses 177.17 123.05 92.68 85.62 75.32 68.30
Miscellaneous Expenses 23.47 43.19 49.36 31.30 11.89 11.11
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,401.18 1,281.60 1,333.96 1,029.95 763.92 692.30
Operating Profit 64.57 46.16 37.55 23.32 21.15 21.71
Interest 3.51 1.98 -7.37 1.79 1.97 2.07
Gross Profit 148.98 63.04 125.54 94.25 37.48 28.61
Depreciation 21.90 18.01 21.19 28.11 34.43 38.01
Profit Before Tax 148.98 63.04 125.54 94.25 37.48 28.61
Tax 38.57 16.60 24.62 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.44 0.20 2.48 0.00 0.00 0.00
Reported Net Profit 110.94 46.24 101.06 94.25 32.33 28.61
Extraordinary Items 148.98 63.04 125.54 94.25 37.48 28.61
Adjusted Net Profit 110.94 46.24 101.06 94.25 32.33 28.61
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 110.94 46.24 101.06 94.25 32.33 28.61
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.17 0.92 2.25 2.10 0.72 0.64
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    35.65%

  • Public Share Holding

    64.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 154,129,838 28.13 154,129,838 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,241,750 7.53 41,241,750 24
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 195,371,588 35.65 195,371,588 35
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 60,000 0.01 60,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,741,824 0.68 3,741,824 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,164,854 2.22 12,164,854 44
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,143,530 0.94 5,143,530 4
Mutual Funds / UTI 13,196 0.00 13,196 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 100,000 0.02 100,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21,223,404 3.87 21,223,404 57
2] Non Institution
Bodies Corporate 19,062,653 3.48 18,428,252 781
Clearing Members 1,276,721 0.23 1,276,721 72
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,526,215 1.37 7,523,232 3,160
Foreign Non Institution Other 38,530,120 7.03 38,530,120 2
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 34,706,909 6.33 29,889,014 113
Individuals holding nominal share capital up to Rs. 1 lakh 230,222,258 42.01 209,218,672 444,134
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 33,831 0.01 33,831 7
Others 0 0.00 0 0
Sub Total 331,358,707 60.47 304,899,842 448,269
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 547,953,699 100.00 521,494,834 448,361

Company Background

Morepen Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen Laboratories Ltd
  • BSE Code : 2685.0
  • ISIN : INE083A01026

  • Incorporation Year

    1984

  • Registered Office

    Morepen Village
    Nalagarh Road Near Baddi, Solan,
    Himachal Pradesh-173205

  • Telephone

    91-01795-276201-03

  • FAX

    91-01795-276204

  • Chairman

    Sushil Suri

  • Managing Director

    Sushil Suri

  • Company Secretary

    Vipul Kumar Srivatava

  • Auditor

    S P Babuta & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Mas Services Limited
    T-34 2nd Floor,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi - 110020

Morepen Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Morepen Labs. 49.36 1,550.16 1,537.59 20.83 17.08
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92